Current:Home > NewsFDA authorizes first revamp of COVID vaccines to target omicron -VanguardEdge
FDA authorizes first revamp of COVID vaccines to target omicron
View
Date:2025-04-15 00:01:08
The Food and Drug Administation authorized reformulated versions of the Moderna and Pfizer-BioNTech vaccines that aim to protect against the omicron variant.
The new shots target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now. This double-barreled vaccine is called a bivalent vaccine.
"The FDA has been planning for the possibility that the composition of the COVID-19 vaccines would need to be modified to address circulating variants. ... We have worked closely with the vaccine manufacturers to ensure the development of these updated boosters was done safely and efficiently," said Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, in an agency statement. "The FDA has extensive experience with strain changes for annual influenza vaccines. We are confident in the evidence supporting these authorizations."
The Moderna COVID-19 vaccine is authorized for use as a single booster dose in people 18 and older. The Pfizer-BioNTech booster is authorized for people 12 years and up. People are eligible for the new boosters two months after completing their initial vaccination or their last booster shot.
The federal government plans to make the boosters available starting next week. In advance of the FDA's decision, Dr. Ashish Jha, the White House COVID-19 Response Coordinator told NPR that the new boosters represented "a really important moment in this pandemic."
Public health officials hope they will help contain a possible fall and winter surge.
But there is also skepticism about how big a difference the boosters can make. "It could be problematic if the public thinks that the new bivalent boosters are a super-strong shield against infection, and hence increased their behavioral risk and exposed themselves to more virus," John Moore, an immunologist at Weill Cornell Medicine in New York, told NPR before the FDA decision.
veryGood! (84)
Related
- Romantasy reigns on spicy BookTok: Recommendations from the internet’s favorite genre
- California Restaurant Association says Berkeley to halt ban on natural gas piping in new buildings
- Kansas legislators pass a bill to require providers to ask patients why they want abortions
- Cases settled: 2 ex-officials of veterans home where 76 died in the pandemic avoid jail time
- USA men's volleyball mourns chance at gold after losing 5-set thriller, will go for bronze
- Suspect used racial slur before fatally stabbing Walmart employee, 18, in the back, police say
- Who owns the ship that struck the Francis Scott Key Bridge in Baltimore?
- Judge tosses out X lawsuit against hate-speech researchers, saying Elon Musk tried to punish critics
- Elon Musk's skyrocketing net worth: He's the first person with over $400 billion
- FBI says Alex Murdaugh lied about where money stolen from clients went and who helped him steal
Ranking
- Realtor group picks top 10 housing hot spots for 2025: Did your city make the list?
- Time, money, lost business are part of hefty price tag to rebuild critical Baltimore bridge
- NFL approves significant changes to kickoffs, hoping for more returns and better safety
- Feds say California’s facial hair ban for prison guards amounts to religious discrimination
- Paris Olympics live updates: Quincy Hall wins 400m thriller; USA women's hoops in action
- Search for survivors in Baltimore bridge collapse called off as effort enters recovery phase
- Finally: Pitcher Jordan Montgomery signs one-year, $25 million deal with Diamondbacks
- Why did the NFL change the kickoff rule and how will it be implemented?
Recommendation
The Daily Money: Spending more on holiday travel?
11-year-old killed in snowmobile crash in northern Maine
How to watch surprise 5th episode of 'Quiet on Set' featuring Drake Bell and other stars
Pregnant Chick-fil-A manager killed in crash with prison transport van before baby shower
Olympic men's basketball bracket: Results of the 5x5 tournament
EU investigating Apple, Google and Meta's suspected violations of new Digital Markets Act
3 moves to make a month before your retirement
Here’s what we know about the allegations against Shohei Ohtani’s interpreter, Ippei Mizuhara